On January 22, 2026, King&Capital Law Firm held an in-depth discussion and exchange with the senior management team of Shenzhen Neptune Star Pharmaceutical Co. The two sides had a frank, pragmatic and constructive dialogue on the compliance challenges faced by pharmaceutical retailers in their rapid expansion and digital transformation, as well as the construction of legal risk prevention and control systems.
During the discussion and exchange, the leaders of the Group shared the basic situation of the enterprise performance, operation, personnel, shareholding structure, etc., predicted the potential legal risk issues unique to the pharmaceutical industry, such as the management of narcotic drugs, the regulation of drugs returning to the medical insurance, the risk of fake drugs production and sale, etc., and put forward the Group's enterprises' urgent legal needs in the areas of criminal compliance, administrative compliance, and industry compliance.
Mr. Tang Jianbin, Director of King&Capital Law Firm, introduced that the center has long been focusing on legal practice and policy research in the fields of environment, food, drugs, intellectual property rights, etc., and has a team of lawyers with multi-disciplinary backgrounds covering criminal, administrative, civil, and compliance, etc., which is committed to providing full-chain and systematic legal solutions for enterprises in related industries.
After exchanging and discussing, the two sides reached a consensus in the following aspects: designing special legal service projects for the most urgent standardization of lease contracts, corporate governance and equity design, etc.; helping enterprises to establish the concept of “Compliance Creates Value” and integrating the awareness of risk control into their corporate strategy and culture by means of executive training, seminars and case sharing. through executive training and case sharing.
Neptune Star is a national retail chain. Its first pharmacy was established in Shenzhen in 1996, and in the mid-1990s, the concept of “chain” was injected into China's commercial retailing sector. Neptune Star Pharmacy has become the largest pharmacy chain with the largest number of directly-managed stores in mainland China, which are located in more than 70 cities in 12 provinces and three municipalities directly under the central government. As a leading pharmaceutical retail chain in China, Neptune has more than 5,000 stores nationwide, with annual sales exceeding 10 billion dollars, and its online business has accounted for 60%-70%.
In this seminar and exchange, Neptune Star's side was led by Peng Yueying, General Manager of the Group Administration Center, with the participation of Chen Jiang, General Manager of the Northern Region and General Manager of the Beijing Division, Liang Xia, Deputy General Manager of the Beijing Division, and Jin Zi, Manager of Administration and Quality of the Beijing Division. Lawyer Tang Jianbin, director of King&Capital Law Firm, and lawyers Wang Zhiqiang, Yan Huainan, Zhang Yongfu and Lv Yan, deputy directors of King&Capital Law Firm, were present at the exchange.
